ADIPOQ and psoriasis: In an in vivo study reduced adiponectin levels in mice, showed increased psoriasiform skin lesions with enhanced infiltration of IL‐17 in the dermal cells,33 In a case‐control study including 50 patients with psoriasis and 50 healthy individuals, the serum levels of adiponectin was evaluated with ELISA.34